TwinStrand Biosciences Duplex Sequencing Technology
TwinStrand Biosciences this week launched TwinStrand Duplex Sequencing Technology kits at the Advances in Genome Biology and Technology meeting. Duplex Sequencing is a biochemistry- and software-based enhancement to existing next-generation sequencing platforms that improves accuracy by more than 10,000-fold, the company said. Optimized chemistry enables users to complete library preparation in one to two days, while cloud-based informatics provide the ability to fully process, analyze, interpret, and graphically present multi-terabyte raw sequencing data. The company will offer its technology initially for two research applications: detection of minimal residual disease in acute myeloid leukemia patients, and a multi-species genetic toxicology assay for rapid identification of carcinogenic chemicals in preclinical testing, as well as detection of patients who have been environmentally exposed.
Blueprint Genetics Mitochondrial Genome Analysis
Blueprint Genetics Mitochondrial Genome Analysis
Blueprint Genetics, a Quest Diagnostics company, has introduced full mitochondrial genome DNA (mtDNA) analysis to its diagnostic panels to increase diagnostic potential across medical specialties such as cardiology, metabolic disease, neurology, ophthalmology, and hearing loss. The analysis uses hybridization-based capture of mtDNA and next-generation sequencing to detect low heteroplasmy levels of mtDNA SNVs, indels, and deletions. It includes sequencing and copy number variant analysis of the entire mitochondrial genome (37 genes) which can be ordered alone or added to any panel. It has also been added to 30 existing panels where mitochondrial DNA testing is expected to have an impact on the diagnostic potential.
S2 Genomics Singulator 100 System
S2 Genomics Singulator 100 System
S2 Genomics this week launched the Singulator 100 System at the Advances in Genome Biology and Technology meeting. The Singulator 100 automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a wide range of single-cell biology and genomic analyses. The company said that this enables researchers to reproducibly prepare suspensions of high-quality, highly viable cells or nuclei with minimal variability. The system will begin shipping in spring of this year with kits available for single-cell and nuclei isolation.
For more new products and services, please visit the New Products page on our website.
For more new products and services, please visit the New Products page on our website.